Regeneron to exclude severely/critically ill COVID-19 patients from antibody cocktail study
Regeneron to exclude severely/critically ill COVID-19 patients from antibody cocktail study
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
2nd study testing a COVID-19 antibody drug has a setback
SeattlePI.com
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety..